Pre-Discharge Bundle for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease to Reduce Readmissions

Not Applicable

Completed

• Conditions: Chronic Obstructive Pulmonary Disease; Exacerbation of Chronic Obstructive Pulmonary Disease
• Interventions: Behavioral: Bundle tool

• Registration Number: NCT02135744
• Lead Sponsor: Henry Ford Health System

Brief Summary

Hospital readmissions for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) pose burdens to the healthcare system and patients. The aim of this study was to determine whether a screening and educational tool, administered prior to discharge, would result in a decrease in the rate of hospital readmissions.

Detailed Description

Hospital readmissions for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) pose burdens to the healthcare system and patients. A current gap in knowledge is whether a pre-discharge screening and educational tool, administered to patients with COPD, reduces readmissions and emergency department (ED) visits.

A single center, randomized trial of patients admitted with AECOPD. Patients will be randomized to control (standard care) or "bundle" group in which patients receive smoking cessation counseling, screening for gastroesophageal reflux disease and depression or anxiety, standardized inhaler teaching, and a 48-hour post-discharge phone call.

Study Timeline

• Study Start: 2010-02
• Primary Completion: 2013-04
• Study Completion: 2013-04
• Study First Submitted: 2014-05-08
• Study First Submitted QC: 2014-05-08
• Study First Posted: 2014-05-12
• Status Verified: 2024-01
• Last Update Submitted: 2024-01-17
• Last Update Posted: 2024-01-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 172

Inclusion Criteria

• diagnosis of COPD with the presence of an AECOPD
• Age > 40
• Current or ex-smoker with history of at least 20 pack-years

Exclusion Criteria

• Past history of asthma, interstitial lung disease, bronchiectasis, presence of airway hardware (e.g. tracheal stents or tracheotomy), lung cancer, any other cancer with a life expectancy of less than 1 year
• Presence of a language barrier
• Residence in a nursing home
• Intensive care unit stay during the current admission
• Delirium or dementia.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Bundle	Bundle tool	Group of patients that receive the screening and educational tool

Primary Outcome Measures

Name	Time	Method
30 day readmission rate	30 days	Time until readmission or ER visit, 30 days

Trial Locations

Locations (1)

Henry Ford Health System; 🇺🇸 Detroit, Michigan, United States